Michael Ellenbogen - 01 Mar 2022 Form 4/A - Amendment Insider Report for Evolv Technologies Holdings, Inc. (EVLV)

Reporting relationship: Founder & Chief Innovation Ofc, Director
Issuer ticker: EVLV
Reported as of: 01 Mar 2022
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 15 Sep 2022, 20:44:52 UTC
Original report date: 03 Mar 2022
Prior SEC filing: 28 Sep 2021
Next SEC filing: 23 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Eric Pyenson, Attorney-in-fact for Michael Ellenbogen

Key filing fact

Michael Ellenbogen filed Form 4/A - Amendment for Evolv Technologies Holdings, Inc. (EVLV) on 15 Sep 2022.

Key facts

This page summarizes Michael Ellenbogen's Form 4/A - Amendment filing for Evolv Technologies Holdings, Inc. (EVLV).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Sep 2022, 20:44.

Change

Previous filing in this sequence was filed on 28 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVLV transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +215,517
Change %
Price: $0.000000
Shares after: 215,517
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 215,517
Exercise price: $3.49
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter.

SEC remarks

This amendment is being filed to amend the original Form 4 filed on March 3, 2022 (the "Original Form 4") solely to correct the exercise price in Column 2 of Table II which was inadvertently incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.